Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FXTF3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,626
Award facts
- Contract value 100% obligated
- $11,626.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,626.18 by the Defense Logistics Agency on January 8, 2026, for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order, which is not set-aside for any specific business category, is scheduled for completion by January 9, 2026, with performance occurring at the company's headquarters location. The award represents a child contract under Cencora, Inc. (doing business as AmerisourceBergen), the parent company that holds significant indefinite delivery contracts with the Defense Logistics Agency.
This delivery order operates under the broader framework of AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle supplying military healthcare programs worldwide. The IDC encompasses a wide array of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to support military treatment facilities, veteran healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FXTF3?
SPE2DR26FXTF3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FXTF3 worth?
The government has obligated $11,626 on SPE2DR26FXTF3.
Is contract SPE2DR26FXTF3 an order under another contract?
Yes. SPE2DR26FXTF3 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXTF3 competed?
The extent of competition for SPE2DR26FXTF3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award